ConductScience.org, home

Paper8530489

Differential modulation of mitogen-activated protein (MAP) kinase/extracellular signal-related kinase kinase and MAP kinase activities by a mutant epidermal growth factor receptor.

Montgomery RB and 4 others. J Biol Chem, 1995. Cited by 80 papers, by iCite.

Cite this record

ConductScience Library. Differential modulation of mitogen-activated protein (MAP) kinase/extracellular signal-related kinase kinase and MAP kinase activities by a mutant epidermal growth factor receptor. Papers, record 8530489. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8530489

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Differential modulation of mitogen-activated protein (MAP) kinase/extracellular signal-related kinase kinase and MAP kinase activities by a mutant epidermal growth factor receptor.
PubMed
Journal
J Biol Chem
PubMed
Year
1995
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
80
iCite
Relative citation ratio, by iCite
1.52
iCite
Revised in PubMed
2021-02-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Montgomery RBR B
2Moscatello DKD K
3Wong AJA J
4Cooper JAJ A
5Stahl WLW L

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Calcium-Calmodulin-Dependent Protein KinasesMajor topic
ErbB ReceptorsMajor topic
Protein KinasesMajor topic
Sequence DeletionMajor topic
3T3 Cells
Animals
Enzyme Activation
Epidermal Growth Factor
Glioblastoma
Humans
Kinetics
Mice
Mitogen-Activated Protein Kinase Kinases
Recombinant Proteins
Tetradecanoylphorbol Acetate
Transfection
Tumor Cells, Cultured
Vanadates

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA 60782-01NCI NIH HHSUnited StatesPubMedPubMed
K08CA060782NIHNIH RePORTER

Download CSV of grants

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.

PMIDTitleJournalYearIn PapersSource
41565660An alternative EGFR activation by patient-derived R252C mutation promotes cancer progression.Nat Commun2026https://conductscience.org/library/papers/41565660PubMed
37368466Mass Spectrometry and Pharmacological Approaches to Measuring Cooption and Reciprocal Activation of Receptor Tyrosine Kinases.Proteomes2023https://conductscience.org/library/papers/37368466PubMed
28745721Helping EGFR inhibition to block cancer.Nat Neurosci2017https://conductscience.org/library/papers/28745721PubMed
28629170EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment.Int J Mol Sci2017https://conductscience.org/library/papers/28629170PubMed
27030122Extracellular ATP protects endothelial cells against DNA damage.Purinergic Signal2016https://conductscience.org/library/papers/27030122PubMed
25885672Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma.Cell Commun Signal2015https://conductscience.org/library/papers/25885672PubMed
25434384Molecularly targeted therapies for recurrent glioblastoma: current and future targets.Neurosurg Focus2014https://conductscience.org/library/papers/25434384PubMed
23429996EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis.Acta Neuropathol2013https://conductscience.org/library/papers/23429996PubMed
22751114Targeting Stat3 and Smad7 to restore TGF-β cytostatic regulation of tumor cells in vitro and in vivo.Oncogene2013https://conductscience.org/library/papers/22751114PubMed
22490227Lyn kinase mediates cell motility and tumor growth in EGFRvIII-expressing head and neck cancer.Clin Cancer Res2012https://conductscience.org/library/papers/22490227PubMed
20472883mTOR signaling in glioblastoma: lessons learned from bench to bedside.Neuro Oncol2010https://conductscience.org/library/papers/20472883PubMed
20461251Phosphotyrosine signaling analysis of site-specific mutations on EGFRvIII identifies determinants governing glioblastoma cell growth.Mol Biosyst2010https://conductscience.org/library/papers/20461251PubMed
19588487EGFRvIII-induced estrogen-independence, tamoxifen-resistance phenotype correlates with PgR expression and modulation of apoptotic molecules in breast cancer.Int J Cancer2009https://conductscience.org/library/papers/19588487PubMed
19560740Targeted therapy for malignant glioma patients: lessons learned and the road ahead.Neurotherapeutics2009https://conductscience.org/library/papers/19560740PubMed
19542748Mutant epidermal growth factor receptor vIII increases cell motility and clonogenecity in a prostate cell line RWPE1.J Endocrinol Invest2009https://conductscience.org/library/papers/19542748PubMed
18812521EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors.Neuro Oncol2009https://conductscience.org/library/papers/18812521PubMed
18628764The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer.Br J Cancer2008https://conductscience.org/library/papers/18628764PubMed
18459149Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities.J Cell Biochem2008https://conductscience.org/library/papers/18459149PubMed
18288481Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer.Histochem Cell Biol2008https://conductscience.org/library/papers/18288481PubMed
16464404Correlative studies in neuro-oncology trials: should they influence treatment?Curr Oncol Rep2006https://conductscience.org/library/papers/16464404PubMed

See all 32 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CDK2023552PubTator's text mininghttps://conductscience.org/library/genes/23552NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
GRB22885PubTator's text mininghttps://conductscience.org/library/genes/2885NCBI Gene
IFI4410561PubTator's text mininghttps://conductscience.org/library/genes/10561NCBI Gene
MAP2K75609PubTator's text mininghttps://conductscience.org/library/genes/5609NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8530489

GET https://conductscience.org/api/papers/v1/8530489/cited_by?page=2